Researchers Angelika Mühlebner

Angelika Mühlebner

Associate Professor - medical

Strategic program(s):

Biography

Medical University Vienna, Vienna, Austria	MD	31-07-2008	medicine
Medical University Vienna, Vienna, Austria		31-08-2009	neuropathology residency
University Hospital Erlangen, Erlangen, Germany	PhD	12-05-2012	epilepsy-associated pathology
Medical University Vienna, Vienna, Austria		31-03-2014	pediatrics residency
Amsterdam Medical Center, AMC, Amsterdam, The Netherlands		31-12-2015	postdoctoral researcher
Amsterdam Medical Center, AMS, Amsterdam, The Netherlands		30-09-2020	pathology residency
University Medical Center Utrecht, Utrecht, The Netherlands	Associate professor	21-12-2021	fellowship neuropathology
University Medical Center Utrecht, Utrecht, The Netherlands		ongoing	neuropathology, head of cytology unit

Strategic program(s):

Contact

amuhleb2@umcutrecht.nl

Pure profile

Research groups

Neuropathology

Research aim

Our aim is to drive and improve state-of-the-art diagnostics, enhance knowlegde and advance targeted interventions for individuals affected by neurological disorders.

Go to group

Recent publications

All publications

Diagnosing primary lateral sclerosis Eva M J de Boer, Bálint S de Vries, Wim Van Hecke, Angelika Mühlebner, Koen L Vincken, Christian P Mol, Wouter van Rheenen, Henk-Jan Westeneng, Jan H Veldink, Günter U Höglinger, Huw R Morris, Irene Litvan, Joost Raaphorst, Nicola Ticozzi, Philippe Corcia, Wim Vandenberghe, Yolande A L Pijnenburg, Harro Seelaar, Caroline Ingre, Philip Van Damme, Leonard H van den Berg, Bart P C van de Warrenburg, Michael A van Es
Journal of Neurology, 2024, vol. 272

Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies Fleur A de Groot, Tim J A Dekker, Jeanette K Doorduijn, Stefan Böhringer, Mirian Brink, Ruben A L de Groen, Lorraine M de Haan, F J Sherida H Woei-A-Jin, Troy Noordenbos, Aniko Sijs-Szabo, Mirjam A Oudshoorn, King H Lam, Arjan Diepstra, Liane C J Te Boome, Valeska Terpstra, Lara H Bohmer, Alina Nicolae, Eduardus F M Posthuma, Lianne Koens, Marc F Durian, Jeroen Stavast, Marjolein W M van der Poel, Myrurgia Abdul Hamid, Wendy B C Stevens, Sjo L M van Rooij, Rimke S Oostvogels, Angelika Mühlebner, Karen J Neelis, Michiel van den Brand, Thomas Tousseyn, Daan Dierickx, Okke de Weerdt, Aart Beeker, Patty M Jansen, Marie José Kersten, Josée M Zijlstra, Martine E D Chamuleau, Hendrik Veelken, Jacoline C E Bromberg, Marcel Nijland, Joost S P Vermaat
European Journal of Cancer, 2024, vol. 213

Diffuse, IDH-wildtype gliomas in adults with minimal histological change and isolated TERT promoter mutation L P Priesterbach-Ackley, F Cordier, P de Witt Hamer, T J Snijders, P A Robe, B Küsters, W W J de Leng, W F A den Dunnen, D Brandsma, C Jansen, P Wesseling, A Muhlebner
Acta Neuropathologica, 2024, vol. 148

Somatostatin receptor 2A expression in von Hippel-Lindau-related hemangioblastomas Saya Ahmad, Angelika Muhlebner, Tom J Snijders, Wendy W de Leng, Tatjana Seute, Rachel S van Leeuwaarde
Cancer, 2024, vol. 130, p.3473-3479

T2-FLAIR Mismatch: An Imaging Biomarker for Children's MYB/MYBL1-Altered Diffuse Astrocytoma or Angiocentric Glioma. E A van Maren, J W Dankbaar, P Wesseling, S Plasschaert, A Muhlebner, E W Hoving, P A Robe, T J Snijders, R Hoogendijk, M E G Kranendonk, M H Lequin
AJNR. American journal of neuroradiology, 2024, vol. 45, p.747-752

Impaired GABAergic regulation and developmental immaturity in interneurons derived from the medial ganglionic eminence in the tuberous sclerosis complex Mirte Scheper, Frederik N F Sørensen, Gabriele Ruffolo, Alessandro Gaeta, Lilian J Lissner, Jasper J Anink, Irina Korshunova, Floor E Jansen, Kate Riney, Wim van Hecke, Angelika Mühlebner, Konstantin Khodosevich, Dirk Schubert, Eleonora Palma, James D Mills, Eleonora Aronica
Acta Neuropathologica, 2024, vol. 147